Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM216A | CCLE | pan-cancer | AAC | -0.2 | 5e-05 |
mRNA | PATJ | CCLE | pan-cancer | AAC | 0.25 | 5e-05 |
mRNA | OVOL2 | CCLE | pan-cancer | AAC | 0.24 | 5e-05 |
mRNA | TMEM55A | CCLE | pan-cancer | AAC | -0.2 | 5e-05 |
mRNA | RHEBL1 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
mRNA | GRAMD2 | CCLE | pan-cancer | AAC | 0.19 | 5e-05 |
mRNA | CISH | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | PTPRN2 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | DSC2 | CCLE | pan-cancer | AAC | 0.22 | 6e-05 |
mRNA | NEK4 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |